Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors
Clinical trial NCT03874273 · UNKNOWN
Trial details
- NCT number
- NCT03874273
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-01
- Primary completion
- 2021-02-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.